Feller-Kopman D, Light R. Pleural disease. N Engl J Med. 2018;378:740–51. https://doi.org/10.1056/NEJMra1403503.
Article CAS PubMed Google Scholar
Bedawi EO, Guinde J, Rahman NM, Astoul P. Advances in pleural infection and malignancy. Eur Respir Rev. 2021;30:200002. https://doi.org/10.1183/16000617.0002-2020.
Article PubMed PubMed Central Google Scholar
Mummadi SR, Stoller JK, Lopez R, Kailasam K, Gillespie CT, Hahn PY. Epidemiology of adult pleural disease in the United States. Chest. 2021;160:1534–51. https://doi.org/10.1016/j.chest.2021.05.026.
Murthy P, Ekeke CN, Russell KL, Butler SC, Wang Y, Luketich JD, et al. Making cold malignant pleural effusions hot: driving novel immunotherapies. Oncoimmunology. 2019;8: e1554969. https://doi.org/10.1080/2162402X.2018.1554969.
Article PubMed PubMed Central Google Scholar
Clive AO, Kahan BC, Hooper CE, Bhatnagar R, Morley AJ, Zahan-Evans N, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014;69:1098–104. https://doi.org/10.1136/thoraxjnl-2014-205285.
Thomas JM, Musani AI. Malignant pleural effusions: a review. Clin Chest Med. 2013;34:459–71. https://doi.org/10.1016/j.ccm.2013.05.004.
Psallidas I, Kanellakis NI, Gerry S, Thézénas ML, Charles PD, Samsonova A, et al. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. Lancet Oncol. 2018;19:930–9. https://doi.org/10.1016/S1470-2045(18)30294-8.
Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol. 2014;50:161–5. https://doi.org/10.1016/j.arbres.2013.11.007.
Wang XJ, Yang Y, Wang Z, Xu LL, Wu YB, Zhang J, et al. Efficacy and safety of diagnostic thoracoscopy in undiagnosed pleural effusions. Respiration. 2015;90:251–5. https://doi.org/10.1159/000435962.
Grosu HB, Kazzaz F, Vakil E, Molina S, Ost D. Sensitivity of initial thoracentesis for malignant pleural effusion stratified by tumor type in patients with strong evidence of metastatic disease. Respiration. 2018;96:363–9. https://doi.org/10.1159/000490732.
Hallifax RJ, Corcoran JP, Ahmed A, Nagendran M, Rostom H, Hassan N, et al. Physician-based ultrasound-guided biopsy for diagnosing pleural disease. Chest. 2014;146:1001–6. https://doi.org/10.1378/chest.14-0299.
Wu YB, Xu LL, Wang XJ, Wang Z, Zhang J, Tong ZH, et al. Diagnostic value of medical thoracoscopy in malignant pleural effusion. BMC Pulm Med. 2017;17:109. https://doi.org/10.1186/s12890-017-0451-1.
Article PubMed PubMed Central Google Scholar
Anevlavis S, Kouliatsis G, Sotiriou I, Koukourakis MI, Archontogeorgis K, Karpathiou G, et al. Prognostic factors in patients presenting with pleural effusion revealing malignancy. Respiration. 2014;87:311–6. https://doi.org/10.1159/000356764.
Yilmaz U, Polat G, Sahin N, Soy O, Gülay U. CT in differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis. 2005;63:17–22. https://doi.org/10.4081/monaldi.2005.653.
Article CAS PubMed Google Scholar
Traill ZC, Davies RJ, Gleeson FV. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol. 2001;56:193–6. https://doi.org/10.1053/crad.2000.0573.
Article CAS PubMed Google Scholar
Heffner JE. Diagnosis and management of malignant pleural effusions. Respirology. 2008;13:5–20. https://doi.org/10.1111/j.1440-1843.2007.01154.x.
Jung MY, Chong A, Seon HJ, Choi S, Kim YH, Shin SS, et al. Indeterminate pleural metastasis on contrast-enhanced chest CT in non-small cell lung cancer: improved differential diagnosis with (18)F-FDG PET/CT. Ann Nucl Med. 2012;26:327–36. https://doi.org/10.1007/s12149-012-0575-6.
Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563–77. https://doi.org/10.1148/radiol.2015151169.
Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173–80. https://doi.org/10.1016/S1470-2045(14)71116-7.
Article PubMed PubMed Central Google Scholar
Lambin P, Leijenaar R, Deist TM, Peerlings J, de Jong E, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749–62. https://doi.org/10.1038/nrclinonc.2017.141.
Han R, Huang L, Zhou S, Shen J, Li P, Li M, et al. Novel clinical radiomic nomogram method for differentiating malignant from non-malignant pleural effusions. Heliyon. 2023;9: e18056. https://doi.org/10.1016/j.heliyon.2023.e18056.
Article PubMed PubMed Central Google Scholar
Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii32–40. https://doi.org/10.1136/thx.2010.136994.
Yang Y, Wu YB, Wang Z, Wang XJ, Xu LL, Tong ZH, et al. Long-term outcome of patients with nonspecific Pleurisy at medical thoracoscopy. Respir Med. 2017;124:1–5. https://doi.org/10.1016/j.rmed.2017.01.005.
Wang F, Zhao Y, Xu J, Shao S, Yu D. Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients. Front Oncol. 2022;12: 1037672. https://doi.org/10.3389/fonc.2022.1037672.
Article PubMed PubMed Central Google Scholar
Haga A, Takahashi W, Aoki S, Nawa K, Yamashita H, Abe O, et al. Standardization of imaging features for radiomics analysis. J Med Invest. 2019;66:35–7. https://doi.org/10.2152/jmi.66.35.
Liu S, Liu S, Zhang C, Yu H, Liu X, Hu Y, et al. Exploratory study of a CT radiomics model for the classification of small cell lung cancer and non-small-cell lung cancer. Front Oncol. 2020;10: 1268. https://doi.org/10.3389/fonc.2020.01268.
Article PubMed PubMed Central Google Scholar
Wu TT, Chen YF, Hastie T, Sobel E, Lange K. Genome-wide association analysis by lasso penalized logistic regression. Bioinformatics. 2009;25:714–21. https://doi.org/10.1093/bioinformatics/btp041.
Article CAS PubMed PubMed Central Google Scholar
Zhang W, Cai W, He B, Xiang N, Fang C, Jia F. A radiomics-based formula for the preoperative prediction of postoperative pancreatic fistula in patients with pancreaticoduodenectomy. Cancer Manag Res. 2018;10:6469–78. https://doi.org/10.2147/CMAR.S185865.
Article PubMed PubMed Central Google Scholar
Ferreiro L, Toubes ME, San José ME, Suárez-Antelo J, Golpe A, Valdés L. Advances in pleural effusion diagnostics. Expert Rev Respir Med. 2020;14:51–66. https://doi.org/10.1080/17476348.2020.1684266.
Article CAS PubMed Google Scholar
Asciak R, Rahman NM. Malignant pleural effusion: from diagnostics to therapeutics. Clin Chest Med. 2018;39:181–93. https://doi.org/10.1016/j.ccm.2017.11.004.
Sundaralingam A, Bedawi EO, Rahman NM. Diagnostics in pleural disease. Diagnostics. 2020;10: 1046. https://doi.org/10.3390/diagnostics10121046.
Article CAS PubMed PubMed Central Google Scholar
Hallifax RJ, Talwar A, Wrightson JM, Edey A, Gleeson FV. State-of-the-art: radiological investigation of pleural disease. Respir Med. 2017;124:88–99. https://doi.org/10.1016/j.rmed.2017.02.013.
Article CAS PubMed Google Scholar
Sun Y, Yu H, Ma J, Lu P. The role of 18F-FDG PET/CT integrated imaging in distinguishing malignant from benign pleural effusion. PLoS ONE. 2016;11: e0161764. https://doi.org/10.1371/journal.pone.0161764.
Article CAS PubMed PubMed Central Google Scholar
Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii4–17. https://doi.org/10.1136/thx.2010.136978.
Kim BS, Kim IJ, Kim SJ, Pak K, Kim K. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients. Onkologie. 2011;34:298–303. https://doi.org/10.1159/000328793.
Comments (0)